Posts Tagged ‘biotech’

On November 6, 2014, Canada passed Vanessa’s Law, a new piece of legislation designed to protect patients from unsafe drugs and medical devices. The law comes after many complaints from citizens that the country wasn’t doing enough to oversee the safety of products sold in the marketplace or the clinical trials being conducted in the […]

Digitally signing documents is easier than you might think. It’s also much faster than having to print, sign, and scan them. And, of course, there’s a significant cost-savings for companies that frequently mail and store hardcopy documents. A product like CoSign can be a great solution for companies, especially those in highly-regulated industries that require […]

What do our pharmaceutical product advertisements indicate about our national ideals, given the myriad of advertisements seen on the Internet, TV, in magazines, or heard on the radio here in the United States? Interestingly, the United States and New Zealand are the only developed nations that allow direct -to-consumer (DTC) advertising (Liang & Mackey, 2011). […]

Senior Management is always looking for answers about what works, what doesn’t, and how best to design and manage clinical trials. In order to get those answers, all of your trial data needs to be in one place and in a consistent format – this is the only way to extract accurate information. But, how […]

There’s a clear trend in the life sciences industry toward outsourcing clinical trial management to clinical research organizations (CROs). If you decide to join the movement, how should you go about getting data from your CROs into your clinical trial management system (CTMS)? The most common method is to collect reports from CROs in the […]

The benefits of minimally invasive surgeries (MIS) are clear: fewer complications, shorter lengths of hospital stays, fewer readmissions, and lower total costs. However, the adoption rate for MIS is surprisingly low. A large medical device client of ours discovered that fewer than 30% of the tens of millions of potential procedures (of interest to them) […]

Inc. magazine recently released its list of the 5,000 fastest-growing private companies in the United States for 2014, ranking companies by overall revenue growth over a three-year period. For the fifth year in a row, BioPharm Systems, a life sciences IT consulting company that Perficient acquired in April 2014, made the list. This accolade is […]

In a few days, Perficient will be attending the 19th Oracle Health Sciences User Group (OHSUG) annual meeting in St. Louis. I have been privileged to attend all previous user group meetings, beginning with the very first one back in 1996 in Ann Arbor, Michigan. Approximately 100 people gathered in a conference room at Parke-Davis […]